BARRIER REVERSE CONVERTIBLE - TEVA PHARMACEUTICAL INDUSTRIES

BARRIER REVERSE CONVERTIBLE - TEVA PHARMACEUTICAL INDUSTRIES Share Price

Certificat

FBCJJB

CH1282662043

Market Closed - Swiss Exchange 16:20:00 19/04/2024 BST
101.7 ^USD	-0.05%

3 months	+1.29%
6 months	+6.38%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Chart BARRIER REVERSE CONVERTIBLE - TEVA PHARMACEUTICAL INDUSTRIES

Latest news about TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Teva and Alvotech Announce SIMLANDI Injection Now Available in the U.S.	05-22	AQ
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.	05-21	BU
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.	05-21	AQ
Teva Pharmaceutical Industries Limited and Alvotech Announce SIMLANDI® Injection Now Available in the U.S	05-21	CI

More news

Static data

Product type	Reverse Convertibles
Buy / Sell	CALL
Underlying	TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Issuer	Bank Julius Bär
	FBCJJB
ISIN	CH1282662043
Date issued	07/09/2023
Strike	9.35 $
Maturity	09/09/2024 (107 Days)
Parity	0.01 : 1
Emission price	100 $
Emission volume	N/A
Settlement	both
Currency	USD

Technical Indicators

Highest since issue	102.2 $
Lowest since issue	95.05 $
Spread	5 $
Spread %	0.49%

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Sector

More about the company